Maduro captured in U.S. strike: what happens next for Venezuela’s oil, politics and markets

Maduro captured in U.S. strike: what happens next for Venezuela’s oil, politics and markets

Venezuela’s PDVSA ordered joint ventures to cut crude output as U.S. forces block oil exports following President Maduro’s capture and transfer to New York on drug charges. A Venezuelan court named Vice President Delcy Rodriguez interim president. No tankers have left the main oil port since Thursday. Regional governments and the UN condemned the U.S. action as a breach of international law.
4 January 2026
Bank of America stock price today: BAC ends Friday up 1.7% as earnings, Fed loom

Bank of America stock price today: BAC ends Friday up 1.7% as earnings, Fed loom

NEW YORK, Jan 4, 2026, 12:15 ET — Market closed Bank of America Corp shares rose 1.7% on Friday to close at $55.95, marking a firmer start to 2026 for the U.S. lender’s stock. U.S. markets are closed on Sunday. The move matters because Wall Street is heading into big-bank earnings season with interest-rate expectations still driving day-to-day swings in financial stocks. Bank of America is scheduled to report fourth-quarter results on Wednesday, Jan. 14. Bank of America Rate bets matter for banks because they influence net interest income — the spread between what lenders earn on loans and securities
Kymera Therapeutics stock extends slide as KYMR closes down 6.5% — what investors watch next

Kymera Therapeutics stock extends slide as KYMR closes down 6.5% — what investors watch next

Kymera Therapeutics shares fell 6.5% to $72.76 on Friday, marking a seventh straight daily loss and leaving the stock down 29% from its early December peak. About 854,000 shares traded as investors shifted focus to 2026 trial milestones and funding. CEO Nello Mainolfi sold 30,000 shares in a pre-arranged plan on Dec. 31. The company raised $602 million in a December stock offering at $86 per share.
4 January 2026
Dow Jones today: Friday rebound lifts the Dow ahead of ISM and jobs data

Dow Jones today: Friday rebound lifts the Dow ahead of ISM and jobs data

The Dow Jones rose 319 points, or 0.7%, to 48,382.39 on Friday, ending a four-day slide as chip and industrial stocks advanced. Tesla fell 2.6% after reporting a second consecutive annual sales drop. The S&P 500 closed at 6,858.47, Nasdaq at 23,235.63. Investors now await Monday’s ISM manufacturing data and Friday’s U.S. jobs report.
Ondas Holdings (ONDS) stock jumps on rebrand plan — three dates traders are watching next

Ondas Holdings (ONDS) stock jumps on rebrand plan — three dates traders are watching next

Ondas shares rose 12.9% to $11.02 Friday after the company announced a planned name change to Ondas Inc. and a headquarters move to West Palm Beach, Florida. A recent filing showed extension of note maturities to Jan. 15. Heavy trading volume reached 136 million shares. Investors await a scheduled share issuance of 2.39 million shares on Jan. 5 tied to earlier exchange agreements.
4 January 2026
BitMine Immersion (BMNR) stock jumps as Tom Lee presses for a 50 billion-share vote

BitMine Immersion (BMNR) stock jumps as Tom Lee presses for a 50 billion-share vote

BitMine Immersion Technologies shares closed up 15% at $31.19 after the company urged shareholders to approve raising its authorized share cap from 500 million to 50 billion. Voting ends Jan. 14, ahead of a Jan. 15 annual meeting in Las Vegas. The company cited financing flexibility and its ether-focused strategy in new SEC filings. About 58 million shares traded in the last session.

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Go toTop